Abstract
Purpose
The aim of the study was to report overall survival, local recurrence and development of metastasis in a group of patients with femur chondrosarcoma that presented with or without a pathological fracture.
Methods
A retrospective review was performed, and 182 patients (39 pathological fractures) that had been treated by oncologic surgery for femoral chondrosarcoma were included. The mean age of the series was 50 years (range, eight to 90) and 114 patients were male (63 %). Mean follow-up was 113 months (range, three to 216). Cancer-specific overall survival, development of metastasis and local recurrence were analysed, grouping patients by grade (grade I / grade 2–3 / dedifferentiated).
Results
Disease-specific survival in the entire group of chondrosarcoma of the femur was 69 % (CI95 % 63–76) at 5 years. Five-year disease-specific survival in the fracture group was 49 % lower than in the control group 75 % (p = 0.0001). Survival of patients with grade 1 chondrosarcoma with fracture was significantly less than those without fracture (p = 0.02) but there was no difference in those with grade 2–3 (p = 0.49) and dedifferentiated tumours (p = 0.09). The local recurrence rate of the entire series was 27 %. Only dedifferentiated chondrosarcomas with an associated pathological fracture had a significantly higher rate of local recurrence. There was no relationship between development of metastases and fracture.
Conclusion
A pathological fracture of the femur has a negative prognostic influence in grade 1 chondrosarcoma and increases the risk of local recurrence in dedifferentiated femur chondrosarcomas.
Similar content being viewed by others
References
Riedel RF, Larrier N, Dodd L et al (2009) The clinical management of chondrosarcoma. Curr Treat Options in Oncol 10(1–2):94–106
Chandrasekar CR, Grimer R, Carter S et al (2011) Outcome of pathologic fractures of the proximal femur in nonosteogenic primary bone sarcoma. Eur J Surg Oncol 37(6):532–536. doi:10.1016/j.ejso.2011.02.007
Puri A, Shah M, Agarwal MG et al (2009) Chondrosarcoma of bone: does the size of the tumor, the presence of a pathologic fracture, or prior intervention have an impact on local control and survival? J Cancer Res Ther 5(1):14–19
Scully SP, H. Temple HT, O’Keefe RJ, Mankin H, et al (1996) The surgical treatment of patients with osteosarcoma who sustain a pathologic fracture. Clin Orthop Relat Res (324): 227–232
Grimer RJ, Cannon SR, Taminiau AM et al (2003) Osteosarcoma over the age of forty. Eur J Cancer 39(2):157–163
Bramer JAM, Abudu A, Grimer RJ et al (2007) Do pathological fractures influence survival and local recurrence rate in bony sarcomas? Eur J Cancer 43(13):1944–1951
Natarajan MV, Govardhan RH, Williams S et al (2000) Limb salvage surgery for pathological fractures in osteosarcoma. Int Orthop 24(3):170–172
Papagelopoulos PJ, Mavrogenis AF, Savvidou OD et al (2008) Pathological fractures in primary bone sarcomas. Injury 39:395–403
Puri A, Shah M, Agarwal MG et al (2009) Chondrosarcoma of bone: does the size of the tumor, the presence of a pathologic fracture, or prior intervention have an impact on local control and survival? J Cancer Res Ther 5(1): 14
Abudu A, Sferopoulos NK, Tillman RM et al (1996) The surgical treatment and outcome of pathological fractures in localized osteosarcoma. J Bone Joint Surg (Br) 78(5):694–698
Salunke AA, Chen Y, Tan JH et al (2014) Does a pathological fracture affect the prognosis in patients with osteosarcoma of the extremities? A systematic review and meta-analysis. Bone Joint J 96-B(10):1396–1403
Bacci G, Ferrari S, Longhi A et al (2003) Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy. Acta Orthop Scand 74:449–454
Moradi B, Zahlten-Hinguranage A, Lehner B, Zeifang F (2010) The impact of pathological fractures on therapy outcome in patients with primary malignant bone tumours. Int Orthop 34(7):1017–1023
Streitbuerger A, Ahrens H, Gosheger G et al (2012) The treatment of locally recurrent chondrosarcoma: is extensive further surgery justified? J Bone Joint Surg (Br) 94(1):122–127
Angelini A, Guerra G, Mavrogenis AF et al (2012) Clinical outcome of central conventional chondrosarcoma. J Surg Oncol 106(8):929–937
Giuffrida AY, Burgueno JE, Koniaris LG et al (2009) Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am 91(5):1063–1072
Chandrasekar CR, Grimer RJ, Carter SR et al (2012) Pathological fracture of the proximal femur in osteosarcoma: need for early radical surgery. ISRN Oncol 2012:512389. doi:10.5402/2012/512389
Lee FY, Mankin HJ, Fondren G et al (1999) Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am 81(3):326–338
Conflict of interest
We can confirm that no financial or personal relationships with other people or organisations could inappropriately influence or bias this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Albergo, J.I., Gaston, C.L., Jeys, L.M. et al. Management and prognostic significance of pathological fractures through chondrosarcoma of the femur. International Orthopaedics (SICOT) 39, 943–946 (2015). https://doi.org/10.1007/s00264-015-2706-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-015-2706-x